Literature DB >> 30109465

Anti-GABAB receptor encephalitis in a patient with gastric adenocarcinoma.

Xiao-Tao Jia1,2, Yanfang Pan3, Zhengli Di4, Naibing Gu4, Zhiqin Liu4, Yu-Ming Kang5.   

Abstract

Anti-γ-aminobutyric acid-B (GABAB) receptor encephalitis is an autoimmune encephalitis associated with antibodies against neuronal cell surface antigens, which are primarily observed with small-cell lung cancer, melanoma, and thymoma. Here, we first report a case on the association between a relatively frequent cancer, gastric adenocarcinoma (GAC), and a rare GABAB receptor antibody limbic encephalitis. The patient was treated with immunotherapy and combined-drug chemotherapy, which were partially effective in terms of stabilizing the tumor and relieving neurological symptoms. This report indicates that, when patients present with GABAB receptor antibody limbic encephalitis, regular and broad screening for tumors including gastric adenocarcinoma should also be considered.

Entities:  

Keywords:  Autoimmune encephalitis; Chemotherapy,; GABAB receptor; Gastric adenocarcinoma; Immunotherapy

Mesh:

Substances:

Year:  2018        PMID: 30109465     DOI: 10.1007/s10072-018-3536-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  GABA content and GAD activity in gastric cancer.

Authors:  M Matuszek; M Jesipowicz; Z Kleinrok
Journal:  Med Sci Monit       Date:  2001 May-Jun

Review 2.  Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens.

Authors:  Luigi Zuliani; Marco Zoccarato; Matteo Gastaldi; Raffaele Iorio; Amelia Evoli; Tiziana Biagioli; Silvia Casagrande; Elena Bazzigaluppi; Raffaella Fazio; Claudia Giannotta; Eduardo Nobile-Orazio; Francesca Andreetta; Ornella Simoncini; Gianna Costa; Sara Mariotto; Sergio Ferrari; Elisabetta Galloni; Michela Marcon; Diego Franciotta; Bruno Giometto
Journal:  Neurol Sci       Date:  2017-10       Impact factor: 3.307

Review 3.  [Autoimmune encephalitis].

Authors:  Albrecht Günther; Julia Schubert; Dirk Brämer; Otto Wilhelm Witte
Journal:  Dtsch Med Wochenschr       Date:  2016-08-24       Impact factor: 0.628

4.  Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

Authors:  Eric Lancaster; Meizan Lai; Xiaoyu Peng; Ethan Hughes; Radu Constantinescu; Jeffrey Raizer; Daniel Friedman; Mark B Skeen; Wolfgang Grisold; Akio Kimura; Kouichi Ohta; Takahiro Iizuka; Miguel Guzman; Francesc Graus; Stephen J Moss; Rita Balice-Gordon; Josep Dalmau
Journal:  Lancet Neurol       Date:  2009-12-02       Impact factor: 44.182

Review 5.  Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review.

Authors:  Yu Uneno; Akira Yokoyama; Yoshitaka Nishikawa; Taro Funakoshi; Yoshinao Ozaki; Ikuo Aoyama; Kiichiro Baba; Daisuke Yamaguchi; Shuko Morita; Yukiko Mori; Masashi Kanai; Hisanori Kinoshita; Takeshi Inoue; Nobukatsu Sawamoto; Riki Matsumoto; Shigemi Matsumoto; Manabu Muto
Journal:  Intern Med       Date:  2016-09-15       Impact factor: 1.271

Review 6.  Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients.

Authors:  Romana Höftberger; Maarten J Titulaer; Lidia Sabater; Balazs Dome; Anita Rózsás; Balazs Hegedus; Mir Alireza Hoda; Viktoria Laszlo; Hendrik Jan Ankersmit; Lutz Harms; Sabas Boyero; Alicia de Felipe; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

7.  Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression.

Authors:  Harry Alexopoulos; Ioannis E Dagklis; Sofia Akrivou; Sevasti Bostantjopoulou; Marinos C Dalakas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-10-29
  7 in total
  1 in total

1.  Encephalitis With Antibodies Against the GABAB Receptor: High Mortality and Risk Factors.

Authors:  Jingfang Lin; Chen Li; Aiqing Li; Xu Liu; Rui Wang; Chu Chen; Dong Zhou; Zhen Hong
Journal:  Front Neurol       Date:  2019-09-26       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.